Billionaire Druckenmiller’s 5 Stocks Picks with Huge Upside Potential

In this piece, we will take a look at billionaire Druckenmiller’s 5 stocks picks with huge upside potential. If you want to read our introduction to Mr. Druckenmiller in general, then head over to Billionaire Druckenmiller’s 10 Stocks Picks with Huge Upside Potential.

5. Transocean Ltd (NYSE:RIG)

Duquesne Capital’s Equity Stake: $15.14 Million
Share Price Upside Potential: 53.06%
Number of Hedge Fund Holders: 47

Transocean Ltd (NYSE:RIG) is a company that offers offshore contract drilling services for oil and gas wells. It is an energy investment play in the portfolio of Duquesne Capital. Transocean Ltd (NYSE:RIG) contracts its mobile offshore drilling rig-related equipment and world crew for drilling oil and gas wells.

In addition to being a billionaire Druckenmiller stock pick with tremendous upside potential, Transocean Ltd (NYSE:RIG) has outperformed the overall market as it is up by about 47% for the year. Analysts have an average $9.75 price target on the stock, implying a 53.06% upside potential from current levels. Druckenmiller acquired 1.8 million shares in Transocean Ltd (NYSE:RIG) in Q3 2023, valued at about $15.14 million and accounting for 0.54% of the portfolio.

As of Q3 2023, 47 of the 910 hedge funds tracked by Insider Monkey held Transocean Ltd (NYSE:RIG) shares, up from 38 in the previous quarter. D. E. Shaw’s D E Shaw was its largest hedge fund shareholder with ownership of about 22 million shares valued at $183.05 million.

[/company-follow-email]

4. Alibaba Group Holding Limited (NYSE:BABA)

Duquesne Capital’s Equity Stake: $26.67 Million
Share Price Upside Potential: 70.81%
Number of Hedge Fund Holders: 110

Alibaba Group Holding Limited (NYSE:BABA) is one billionaire Druckenmiller stock pick with tremendous upside potential that offers exposure to the Chinese internet landscape. The company is one of the largest e-commerce players, offering platforms that connect merchants with sellers. Alibaba Group Holding Limited (NYSE:BABA) also provides a cloud computing unit with storage, analytics, and cybersecurity solutions.

Alibaba Group Holding Limited (NYSE:BABA) has underperformed the overall market, down by about 17% for the year. Nevertheless, analysts rate it as a Buy with an average price target of $124.74, implying 70.81% upside potential. Alibaba Group Holding Limited (NYSE:BABA) is one of the new additions to Druckenmiller’s portfolio, with the acquisition of stakes worth $26.67 million in Q3 2023 accounting for 0.95% of the portfolio.

During Q3 2023, 110 out of the 910 hedge funds part of Insider Monkey’s database were Alibaba Group Holding Limited (NYSE:BABA)’s shareholders. Alibaba Group Holding Limited (NYSE:BABA)’s most significant investor during Q3 was Ken Fisher’s Fisher Asset Management as it owned $334 million worth of shares.

[/company-follow-email]

3. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Duquesne Capital’s Equity Stake: $6.94 Million
Share Price Upside Potential: 124.02%
Number of Hedge Fund Holders: 19

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a healthcare investment in Duquesne Capital’s portfolio that operates as a clinical-stage biotechnology company. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) leverages technological innovations, data science, and engineering to enhance drug discovery. It is currently working on REC 994 to treat cerebral cavernous malformation.

While Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is down by about 4% for the year, it is one of the billionaire Druckenmiller stock picks with tremendous upside potential. Analysts on Wall Street rate it as a Buy with an average price target of $16.60, implying 124.02% upside potential from current levels. Druckenmiller reduced his stock exposure in Q3 2023 by 35% to $6.9 million, accounting for 0.24% of the portfolio.

As per Insider Monkey’s database, 19 hedge funds held stakes in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) in Q3 2023, compared to 15 funds in the prior quarter. Mubadala Investment’s 

MIC Capital Partners is the leading shareholder of the company, with stakes worth $64.66 million.

[/company-follow-email]

2. IHS Holding Limited (NYSE:IHS) 

Duquesne Capital’s Equity Stake: $3.42 Million
Share Price Upside Potential: 144.68%
Number of Hedge Fund Holders: 14

London-based IHS Holding Limited (NYSE:IHS) is a communication services company that owns, operates, and develops shared communications infrastructure. IHS Holding Limited (NYSE:IHS) primarily works in Latin America, Sub-Saharan Africa, and the Middle East. 

IHS Holding Limited (NYSE:IHS) has underperformed the overall market, going down 24% year to date. Nevertheless, IHS Holding Limited (NYSE:IHS) remains one billionaire Druckenmiller’s stock picks with huge upside potential going by the $11.50 price target, which implies 144.68% upside potential.

Out of the 910 hedge funds tracked by Insider Monkey, 14 funds had investments in IHS Holding Limited (NYSE:IHS)’s stock in the third quarter, down from 15 in the previous quarter.

[/company-follow-email]

1. AbCellera Biologics Inc. (NASDAQ:ABCL)

Duquesne Capital’s Equity Stake: $3.04 Million
Share Price Upside Potential: 417.24%
Number of Hedge Fund Holders: 17

AbCellera Biologics Inc. (NASDAQ:ABCL) is billionaire Druckenmiller’s top stock pick with tremendous upside potential with operations in the healthcare sector. AbCellera Biologics Inc. (NASDAQ: ABCL) values its research collaboration and license agreement with Eli Lilly.

Druckenmiller has held stakes in AbCellera Biologics Inc. (NASDAQ:ABCL) since the fourth quarter of last year at the height of the bear run. Duquesne Capital held stakes worth $3 million in the company in Q3 2023, accounting for 0.1% of the portfolio. While AbCellera Biologics Inc. (NASDAQ:ABCL) is down by about 52%, analysts on Wall Street are bullish about its prospects, with a $24 price target implying a 417.24% upside potential.

In the third quarter of 2023, 17 hedge funds had stakes in AbCellera Biologics Inc. (NASDAQ:ABCL), according to Insider Monkey’s database. Baker Bros. Advisors, led by Julian Baker and Felix Baker, was the leading stakeholder in the company.

[/company-follow-email]

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 15 Stocks under $50 to Buy and Hold Forever and Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 12 Stock Picks.